glp-1 and statins lower your body's levels Treatment of High-Risk Patients with

JCI Insight 2020;5:e134796

8 History of pancreatitis Finally, it is essential to determine the etiology of previous episodes of pancreatitis before starting GLP-1 receptor agonist treatment

The primary outcome is simple but meaningful: How many heavy drinking days per week they have at the end of the study compared to when they started. Secondary outcomes include changes in WHO risk categories and levels of phosphatidylethanol, a blood biomarker for alcohol use

Patients with GLP-1 therapy often differ in important respects from other patients - for example, in general health status, access to medical care, or treatment intensity

In patients with known serious hypersensitivity to insulin glargine, lixisenatide, or to any of the product components